I'm sorry, I didn't catch your name http://xxxnx.fun/britt-james-boobpedia/ braty sister The FDA submission is based on a trial presented at the American Society for Clinical Oncology meeting in June. Nexavar almost doubled progression-free survival, to a median of 10.8 months in patients treated with it, compared with 5.8 months in control patients. Bayer filed for FDA approval soon after.